For a manuscript include Full title and if mandatory add short title. The full title can be of 250 Characters and short title up to 60 characters. The title should be in title case (all the words should be capitalized except prepositions and conjunctions) and font should be Times New Roman and font size 15.

Author list and Affiliation

In the manuscript the author names and affiliations along with corresponding author details should be listed.

The author names can be in the following order.

  •  First name (or initials, if used)
  •  Middle name (or initials, if used)
  •  Last name (surname, family name)

Each author on the list must have an affiliation. The affiliation should include department, university, or organizational affiliation and its location, including city, state/province (if applicable), and country followed by telephone, fax and email id.

One corresponding author should be designated in the submission system as well as on the title page. One corresponding author should be designated in the submission system. However, this does not restrict the number of corresponding authors that may be listed on the article in the event of publication.

Cover letter

It is essential to upload a cover letter as a separate file while submission and can be a maximum of 1 page length.

  •  Specify the article type (for example, research article, systematic review, Short Communication, clinical trial)
  •  It presents the original work of the authors
  •  Summarize the study's contribution to the scientific literature
  •  Suggest maximum of 2 reviewers for your manuscript and also should include the list of opposed reviewers.
  •  Relate the study or your submission to previously published work.
  •  All the authors have read and approved the final version of the manuscript.

Title Page

The title, authors, affiliations along with corresponding author details should be included in the title page as the first page of the manuscript file.


The abstract should immediately follow the title page in the manuscript file.

The Abstract should:

  •  Be accurate and should Describe the main objective(s) of the study
  •  Not exceed 300 words
  •  Please avoid the use of citations and Abbreviations in your abstract
  •  Explain how the study was done, without methodological detail and the abstract must be accurate as a reflection of your research.
  •  Summarize the most important results and their significance also state the main outcomes and results, and state the conclusions that might be drawn from these data and results, including their implications for further research or application/practice.

Key Words

In a manuscript a maximum of 8 Key words can be used. It can include the key areas covered, variables tested, and the major response criteria. The first letter of each word should be capitalised and each key word should be separated by a semicolon and the key words should be italicized. Key words will assist indexers in cross-indexing the article and may be published with the abstract.


The abbreviations should be defined upon first appearance in the text; we suggest avoiding the usage of non-standard abbreviations unless they appear at least three times in the text. Each word or a phrase should be separated with colon, and the abbreviation should be separated with semi colon


The introduction should:

  •  Provide background that puts the manuscript into context and lets in readers outside the sphere to understand the motive and significance of the study.
  •  Include brief analysis on review of literature.
  •  Define the research or case addressed and why it is important
  •  Note any relevant controversies or disagreements in the field
  •  The main and secondary objectives should be made clear, and any pre-specified subgroup analysis should be described.
  •  Reports of clinical research should, where appropriate, include a summary of a search of the literature to indicate why this study was necessary and what it aimed to contribute to the field.
  •  Conclude with a brief statement of the overall aim of the work and a comment about whether that aim was achieved.

Materials and Methods

The Materials and Methods section should provide enough detail to allow researchers and scientists to fully replicate your study. Specific information and/or protocols for new methods should be included in detail. If materials, methods, and protocols are well established, authors may cite articles where those protocols are described in detail, but the submission should include sufficient information to be understood independent of these references.

We encourage authors to submit detailed methods and protocols as supplementary files and supporting information.

Hendun journals require authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception.

For smaller data sets and certain data types, authors may provide their data within supporting information files accompanying the manuscript. Authors should take care to maximize the accessibility and reusability of the data by selecting a file format from which data can be efficiently extracted (for example, spread sheets or flat files should be provided rather than PDFs when providing tabulated data).

Authors reporting research using cell lines should state when and where they obtained the cells, giving the date and the name of the researcher, cell line repository, or commercial source (company) who provided the cells, as appropriate.

Results, Discussion, Conclusions

Present your results in a logical sequence These sections may all be separate, or may be combined to create a mixed Results/Discussion section (commonly labelled "Results and Discussion") or a mixed Discussion/Conclusions section (commonly labelled "Discussion"). These sections may be further divided into subsections, each with a concise subheading, as appropriate. These sections have no word limit, but the language should be clear and concise.

Authors should explain how the results relate to the experimental method presented as the basis of the study and provide a concise explanation on the insinuation of the findings, particularly in relation to previous related studies and potential future directions for research.

Results section may be further divided into subsections, each with a concise subheading, as appropriate. These sections have no word limit, but the language should be clear and concise.

This division of this manuscript should include the points that should be concluded according to the assumptions made and the conclusions should stick to the point mentioned in the method followed.


This section in the manuscript should present all the members contributed to the work and description of their contribution.

If the research is a funded work the grant details along with grant numbers can be presented. The funds or funding source can also be included.


Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference proceedings, abstracts or papers that have been submitted but not yet accepted should not be cited. All personal communications should be supported by a letter from the relevant authors.

Hendun Research Access employees the name-year (or "Harvard") system of in-text references, in which the author's surname and year of publication are cited in the text of your work, enclosed in parentheses. The reference list (appearing at the end of the article) should be numbered in the order that they appear in the text.

All references in text, tables, and legends must be identified by consecutive Arabic numerals in square brackets, listed immediately before the closing punctuation mark. E.g. [1] or [1,2] or [2-6] or [2-6,8] or [1,2,6-8] or [1,5-8,9, 12-20].

Anglia Ruskin University Library has produced a very useful Guide to the Harvard System of Referencing, which we have shown here for your consult.

Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is crucial. Please use the following style for the reference list:


  •  Ogino S, Wilson RB (2004) Spinal muscular atrophy: molecular genetics and diagnostics. Expert Rev Mol Diagn 4: 15-29. [Crossref]
  •  Lemoine TJ, Swoboda KJ, Bratton SL, Holubkov R, Mundorff M, et al. (2012) Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival? Pediatr Crit Care Med 13: e161-165. [Crossref]
  •  Wirth B, Brichta L, Hahnen E (2006) Spinal muscular atrophy: from gene to therapy. Semin Pediatr Neurol 13: 121-131. [Crossref]

Note: Please list the first five authors and then add "et al." if there are additional authors.

Electronic Journal Articles Entrez Programming Utilities

The Entrez Programming Utilities (E-utilities) are a set of eight server-side programs that provide a stable interface into the Entrez query and database system at the National Centre for Biotechnology Information (NCBI).

Please refer the link provided for related queries click


  •  Lemoine TJ (2006) Principles of drug disposition in domestic animals: The basis of Veterinary Clinical Pharmacology. (1stedn), W.B. Saunders Company, Philadelphia, London, Toranto.
  •  Wirth B (2006) Bioinformatics tools for differential analysis of proteomic expression profiling data from clinical samples. Taylor & Francis CRC Press.


  •  Zhang Z (2006) The Cluster-Abstraction Model: unsupervised learning of topic hierarchies from text data. Proceedings of the International Joint Conference on Artificial Intelligence.


We strongly encourage the authors to submit tables as .doc format. The usage of tables should be minimum and as simple as possible.

The tables presented should not be copied directly from the internet source and should not be embedded as objects; the tables should be typed double-spaced throughout, including headings and footnotes. Each table should be on a separate page, numbered consecutively in Arabic numerals and supplied with a heading and a legend.

The tables presented should be easily understood without reference to the text. Preferably, the details of the methods used in the experiments should be described in the legend instead of in the text. The same data should not be presented in both table and graph form or repeated in the text.

Note:If the submission is in PDF format, the author is requested to retain the same in .doc format in order to aid in completion of process successfully.


The following file formats are accepted for figures submitted to Hendun Research Access: JPEG, .doc, PNG, TIFF, GIF and Power Point. The lettering, decimals, lines and other details on the figure must be sufficiently large to withstand reduction and reproduction. Do not include images in the main manuscript text file.

All images must be at or above intended display size, See the Image quality specifications chart for details.

Mention the figure numbers in the text at the appropriate places in parenthesis before the punctuation marks. e.g. (Figure 1) or (Figure 1A, 2) or (Figure 1A, 1B, 3-5) or (Figures 1-3) or (Figures 1, 2-4).

The file name should include the figure number. Label file names as: Figure1, Figure2 etc. If multiple figures form a part of a sequence label them as Figure 1(A), Figure 1(B) etc.

Figure Legends: Please provide figure legends on a separate page with Arabic numerals corresponding to the figures.

Supporting Information or Supplementary Information

Authors can submit essential supplementary files and multimedia files along with their manuscripts. All the supporting information will be subject to peer review. All file types can be submitted, but files must be smaller than 10 MB in size.

Authors may use almost any description as the item name for a supporting information file as long as it contains an "S" and number. For example, "S1 Appendix", "S1 Table" and "S2 Table," "S1 Figure" and so forth.

Supplementary files are published exactly as provided, and are not copyedited and will be uploaded separately along with the manuscript.